NCT06119880View on ClinicalTrials.gov

The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Pancreatic Exocrine InsufficiencyPancreatic Enzyme Replacement TherapyPancreaticoduodenectomy
Interventions
DRUG

Pancreatin Enteric-coated Capsules

pancreatic enzyme replacement therapy

OTHER

Routine treatment plan

Routine treatment plan without PERT

Trial Locations (1)

200025

RECRUITING

Shanghai Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER